255 related articles for article (PubMed ID: 7812011)
21. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers.
Kaplan MA; Ferry JA; Harris NL; Jacobson JO
Am J Clin Pathol; 1994 May; 101(5):590-6. PubMed ID: 8178765
[TBL] [Abstract][Full Text] [Related]
22. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
23. bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders.
Chetty R; Biddolph S; Kaklamanis L; Cary N; Stewart S; Giatromanolaki A; Gatter K
J Pathol; 1996 Nov; 180(3):254-8. PubMed ID: 8958801
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of primary mediastinal B cell lymphoma.
Tsang P; Cesarman E; Chadburn A; Liu YF; Knowles DM
Am J Pathol; 1996 Jun; 148(6):2017-25. PubMed ID: 8669486
[TBL] [Abstract][Full Text] [Related]
25. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
[TBL] [Abstract][Full Text] [Related]
26. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies.
Hanto DW
Annu Rev Med; 1995; 46():381-94. PubMed ID: 7598473
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease.
Patton DF; Wilkowski CW; Hanson CA; Shapiro R; Gajl-Peczalska KJ; Filipovich AH; McClain KL
Transplantation; 1990 Jun; 49(6):1080-4. PubMed ID: 2163133
[TBL] [Abstract][Full Text] [Related]
28. Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus.
Suzushima H; Asou N; Fujimoto T; Nishimura S; Okubo T; Yamasaki H; Osato M; Matsuoka M; Tsukamoto A; Takai K
Blood; 1995 Jan; 85(2):480-6. PubMed ID: 7812002
[TBL] [Abstract][Full Text] [Related]
29. Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease.
Blokx WA; Andriessen MP; van Hamersvelt HW; van Krieken JH
Am J Dermatopathol; 2002 Oct; 24(5):414-22. PubMed ID: 12357204
[TBL] [Abstract][Full Text] [Related]
30. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
Tanner JE; Alfieri C
Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
[TBL] [Abstract][Full Text] [Related]
31. BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders.
Murray PG; Swinnen LJ; Constandinou CM; Pyle JM; Carr TJ; Hardwick JM; Ambinder RF
Blood; 1996 Jan; 87(2):706-11. PubMed ID: 8555494
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.
Dotti G; Fiocchi R; Motta T; Gamba A; Gotti E; Gridelli B; Borleri G; Manzoni C; Viero P; Remuzzi G; Barbui T; Rambaldi A
Transplantation; 2000 Mar; 69(5):827-33. PubMed ID: 10755535
[TBL] [Abstract][Full Text] [Related]
33. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease.
Walling DM; Andritsos LA; Etienne W; Payne DA; Aronson JF; Flaitz CM; Nichols CM
J Med Virol; 2004 Sep; 74(1):94-101. PubMed ID: 15258974
[TBL] [Abstract][Full Text] [Related]
34. Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome.
Nakanishi M; Kikuta H; Tomizawa K; Kojima K; Ishizaka A; Okano M; Sakiyama Y; Matsumoto S
Cancer; 1993 Aug; 72(4):1376-81. PubMed ID: 8393374
[TBL] [Abstract][Full Text] [Related]
35. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation.
Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ
Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997
[TBL] [Abstract][Full Text] [Related]
36. T gamma/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report.
Kraus MD; Crawford DF; Kaleem Z; Shenoy S; MacArthur CA; Longtine JA
Cancer; 1998 Mar; 82(5):983-92. PubMed ID: 9486591
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation.
Montone KT; Litzky LA; Wurster A; Kaiser L; Bavaria J; Kotloff R; Palevsky H; Pietra GG; Tomaszewski JE
Surgery; 1996 May; 119(5):544-51. PubMed ID: 8619211
[TBL] [Abstract][Full Text] [Related]
38. Isolated pleural PTLD after cardiac transplantation.
Lamba M; Jabi M; Padmore R; Sengar DP; Veinot JP
Cardiovasc Pathol; 2002; 11(6):346-50. PubMed ID: 12459436
[TBL] [Abstract][Full Text] [Related]
39. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
[TBL] [Abstract][Full Text] [Related]
40. Selective outgrowth of a posttransplant B-immunoblastic lymphoma expressing a latent membrane protein-1 deletion variant.
Kershaw GR; Berger C; McQuain C; al-Homsi AS; Pihan G; Quesenberry PJ; Woda BA; Knecht H
Transplantation; 1997 Oct; 64(7):1079-81. PubMed ID: 9381534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
